NIH #R01CA279128
Urothelial Resurfacing with Irreversible Electroporation for Adjuvant Therapy of Bladder Cancer
Active
- Amount
- $700K–$800K
- Period
- 2026-06-11 → 2031-05-31
- PIs
- 2
Awarded at UNIVERSITY OF MASSACHUSETTS AMHERST
Jonathan Coleman
Full Professor(heuristic)
Renal cell carcinoma treatment · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index65
i10-index200
Publications740
Citations22,340
Grants
2 total · 2 active
NIH #R01NS134558
Deciphering the Molecular Mechanisms of Neurotransmitter Transport
Active
- Amount
- $400K–$500K
- Period
- 2023-12-01 → 2028-11-30
- PIs
- 1
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New NIH award: Urothelial Resurfacing with Irreversible Electroporation for Adjuvant Therapy of Bladder Cancer2026-06-11
- New preprint: Two-Year Outcomes from the PRESERVE Trial: Durable Oncologic Control Following Focal Irreversible Electroporation Ablation for Intermediate-Risk Prostate Cancer2026-05-13
- New paper: Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma (Cancers)2025-11-29
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0002-6428-7835